With more than 26 million Americans currently suffering from Alzheimer’s (that number is expected to quadruple by 2050), early detection is critical in limiting the effects of this disease and optimizing available treatments. New research is showing that variations in eye structure may be able to detect the disease before symptoms arise.
As we’ve shared previously, the accumulation of amyloid beta protein deposits in the eye can help detect the presence of Alzheimer’s. New research being conducted by the investigators at Cedars-Sinai Regenerative Medicine Institute is showing that certain variations in eye structure may aid in early detection. Since optometrists are already a critical part of health teams in the detection of many other systemic diseases, the early detection of Alzheimer’s through eye exams would be a major breakthrough.
Researchers at Cedars-Siani studied postmortem human retinas and animal models and found that changes in the retinal pigment epithelial layer and the thickness of the choroidal layer detected by advanced imaging devices were strongly indicative of Alzheimer’s disease. Considering their findings, they have reason to believe further study may prove to be beneficial, not only in the early detection of Alzheimer’s, but possibly in the development of treatments and drug …![]()